KREBSBIOKrebs Biochemicals & IndustriesKREBSBIO info
$0.99info-1.24%24h
Global rank29836
Market cap$21.34M
Change 7d-0.30%
YTD Performance7.37%
SP500 benchmarkUnderperform
P/E-0.09
P/S3.43
Revenue$6.22M
Earnings-$2.94M
Dividend yield-
Main Sector
Healthcare

Krebs Biochemicals & Industries KREBSBIO Total Debt

KREBSBIO Total Debt in 2022: $26.02M

According to Krebs Biochemicals & Industries latest financial reports the total debt is $26.02M, an increase of 22.66% to 2022. At the end of 2022 company had $21.21M total debt. This figure represents the debts and financial obligations that Krebs Biochemicals & Industries combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.

Krebs Biochemicals & Industries KREBSBIO Total Debt History from 2023 to 2022

-
Value:-

KREBSBIO Total Debt by year

YearTotal debtChange
2023$26.02M22.66%
2022$21.21M53.99%
2021$13.78M43.53%
2020$9.60M-11.50%
2019$10.85M-

View the Top Total Debt Stocks arrow right

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org